PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12738840

Embryonic stem cells. Stem cell programs.

Elias Zerhouni
View original source ↗Export metadata ↓

Abstract

The availability of human embryonic stem cell lines provides an important tool for scientists to explore the fundamental mechanisms that regulate differentiation into specific cell types. When more is known about the mechanisms that govern these processes, human embryonic stem cells may be clinically useful in generating cell types that have been damaged or depleted by a variety of human diseases. The NIH is actively pursuing a variety of initiatives to promote this developing research field, while continuing and expanding its long-standing investment in adult stem cells and research.

Explore related subjects

Advisory CommitteesCell Culture TechniquesCell LineEducationEmbryo ResearchEmbryo, MammalianExpressed Sequence TagsFinancing, GovernmentHumansInternetNational Institutes of Health (U.S.)Patents as TopicResearch Support as TopicStem CellsUnited StatesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Elias Zerhouni. 2003-05-09. Embryonic stem cells. Stem cell programs.. https://doi.org/10.1126/science.1084819

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2022

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus among hematopathologists, geneticists, molecular scientists, and clinicians. Significant progress has recently been made in the characterization of malignancies of the immune system, with many new insights provided by genomic studies. They have led to this proposal. We have followed the same process that was successfully used for the third and fourth editions of the World Health Organization Classification of Hematologic Neoplasms. The definition, recommended studies, and criteria for the diagnosis of many entities have been extensively refined. Some categories considered provisional have now been upgraded to definite entities. Terminology for some diseases has been revised to adapt nomenclature to the current knowledge of their biology, but these modifications have been restricted to well-justified situations. Major findings from recent genomic studies have impacted the conceptual framework and diagnostic criteria for many disease entities. These changes will have an impact on optimal clinical management. The conclusions of this work are summarized in this report as the proposed International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors.

Advisory Committees↗